Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Vivacta gears up production of new piezofilm sensors used by Point of Care diagnostics systems

Vivacta : 29 May, 2008  (Company News)
Vivacta is gearing up for pilot manufacture of its highly sensitive, disposable piezofilm sensors for Point of Care (PoC) diagnostics by acquiring an extra 6,000ft2 of space within its Kent Science Park facility and appointing an experienced engineering manager.
Doubling the size of its operation will allow Vivacta to establish a fully equipped Cartridge Pilot Facility. The facility will act as a process development resource for both its own Development Group and its technology licensees.

The new facility’s main role will be to develop and optimise the process of cartridge manufacture as well as producing batches of up to 10,000 cartridges for internal evaluation and external clinical trials. Vivacta is already evaluating the first PoC application of its patented piezofilm technology, for the measurement of TSH.

To run the new facility, Vivacta has appointed Stafford Moss, as engineering manager. Moss brings a wealth of experience to the new operation, having held a similar position at Genosis, a Point-of-Care fertility testing business.

Commenting on this latest stage of Vivacta’s development, Neil Butler, chief executive officer, said, “When we raised $12 million from a successful Series B financing round in 2007, we said it would be used to drive forward the commercialisation and launch of our first Point of Care (PoC) immunoassay system. Acquiring the necessary space for the creation for our Cartridge Pilot Facility, together with the appointment of Stafford Moss, takes us another major step closer to the launch of our first commercial Assay and harnessing the speed and sensitivity of our piezofilm technology.

In addition to Moss, Vivacta will be recruiting 10 extra staff over the next nine months as the new facility ramps up its manufacturing and QC functions.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo